Overview

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
A study of the safety and efficacy of Infliximab (Remicade) versus placebo in subjects with Ankylosing Spondylitis
Phase:
Phase 3
Details
Lead Sponsor:
Centocor, Inc.
Collaborator:
Centocor BV
Treatments:
Infliximab